Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

By Stephanie Brown HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Infection-causing fungi responsible for millions of deaths a year will spread significantly to new regions as the planet ...

GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval ...

GSK (LSE:GSK) recently received FDA approval for Nucala for COPD treatment, potentially enhancing its market presence.

GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...

A new study forecasts that climate change will enable Aspergillus, a fungus causing the deadly disease aspergillosis, to ...

FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients ...

Global warming and natural disasters are taking a toll on people’s health. Here are 3 things HR can do to protect employees and lower their healthcare spend.

The City of Jacksonville’s Office of Administrative Services is issuing an air quality advisory today because of elevated ...

Indian pharma is building a sustainability framework focused on green energy, water stewardship, and circular innovation to ...